EFFICACY OF TARGETED THERAPIES IN HEMATOLOGIC MALIGNANCIES: A CLINICAL OUTCOME STUDY. Biology and Biotechnology Communications, [S. l.], v. 3, n. 02, p. 39–61, 2025. DOI: 10.67079/bbc.0230. Disponível em: https://biotech-journal.com/index.php/BBCJ/article/view/30. Acesso em: 25 may. 2026.